Back
BioCryst Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
BCRX
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
35
BCRX
BioCryst Pharmaceuticals
Last Price:
8.16
Seasonality Move:
-9.69%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund managerBioCryst Pharmaceuticals Price Quote
$8.16
+0.19 (+2.38%)
(Updated: September 19, 2024 at 6:55 PM ET)
BioCryst Pharmaceuticals Key Stats
Sell
35
BioCryst Pharmaceuticals (BCRX)
is a Sell
Day range:
$7.91 - $8.25
52-week range:
$4.03 - $8.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.19
P/B ratio:
0%
Volume:
1.7M
Avg. volume:
1.8M
1-year change:
5.84%
Market cap:
$1.6B
Revenue:
$331.4M
EPS:
$-0.73
How Much Does BioCryst Pharmaceuticals Make?
-
How Much Are BioCryst Pharmaceuticals's Sales Annually?
BCRX Revenues are $331.4M -
How Much Profit Does BioCryst Pharmaceuticals's Make A Year?
BCRX net income is -$226.5M
Is BioCryst Pharmaceuticals Growing As A Company?
-
What Is BioCryst Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.33% -
What Is BioCryst Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
BioCryst Pharmaceuticals Stock Price Performance
-
Did BioCryst Pharmaceuticals Stock Go Up Last Month?
BioCryst Pharmaceuticals share price went up by 4.32% last month -
Did BCRX's Share Price Rise Over The Last Year?
BCRX share price rose by 5.84% over the past 1 year
What Is BioCryst Pharmaceuticals 52-Week High & Low?
-
What Is BioCryst Pharmaceuticals’s 52-Week High Share Price?
BioCryst Pharmaceuticals has traded as high as $8.88 over the past 52 weeks -
What Is BioCryst Pharmaceuticals’s 52-Week Low Share Price?
BioCryst Pharmaceuticals has traded as low as $4.03 over the past 52 weeks
BioCryst Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy BioCryst Pharmaceuticals?
-
How Much Debt Does BioCryst Pharmaceuticals Have?
Total long term debt quarterly is $808.5M -
How Much Cash Does BioCryst Pharmaceuticals Have?
Cash and short term investments quarterly total is $272M -
What Is BioCryst Pharmaceuticals’s Book Value Per Share?
Book value per share is -2.30
Is BioCryst Pharmaceuticals Cash Flow Positive?
-
What Is BCRX Cash Flow From Operations?
Cash flow from operations (TTM) is -$83.9M -
What Is BioCryst Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$5M -
What Is BioCryst Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $21M
BioCryst Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
BCRX return on invested capital is -38.85% -
What Is BioCryst Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -29.07% -
What Is BCRX Return On Equity?
ROE is a measure of profitability and is 0%
BioCryst Pharmaceuticals Earnings Date & Stock Price
-
What Is BioCryst Pharmaceuticals's Stock Price Today?
A single share of BCRX can be purchased today for 7.97 -
What Is BioCryst Pharmaceuticals’s Stock Symbol?
BioCryst Pharmaceuticals trades on the nasdaq under the ticker symbol: BCRX -
When Is BioCryst Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for BioCryst Pharmaceuticals is scheduled on November 1, 2024 -
When Is BCRX's next ex-dividend date?
BioCryst Pharmaceuticals's next ex-dividend date is September 20, 2024 -
How To Buy BioCryst Pharmaceuticals Stock?
You can buy BioCryst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BioCryst Pharmaceuticals Competitors
-
Who Are BioCryst Pharmaceuticals's Competitors?
Below is a list of companies who compete with BioCryst Pharmaceuticals or are related in some way:
BioCryst Pharmaceuticals Dividend Yield
-
What Is BCRX Dividend Yield?
BioCryst Pharmaceuticals’s dividend yield currently is 0% -
What Is BioCryst Pharmaceuticals’s Payout Ratio?
BioCryst Pharmaceuticals’s payout ratio is 0% -
When Did BioCryst Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is BioCryst Pharmaceuticals’s Dividend Per Share?
BioCryst Pharmaceuticals pays a dividend of $0.00 per share
BioCryst Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 63.28% |
Revenue: | 32.54% | 11.2% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 13.90 |
Upside from Last Price: | 74.4% |